- idUS
- Listar por autor
Listar por autor "Danhof, Sophia"
Mostrando ítems 1-3 de 3
-
Artículo
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells
García-Guerrero, Estefanía; Rodríguez-Lobato, Luis G.; Sierro-Martínez, Belén; Danhof, Sophia; Bates, Stephan; Frenz, Silke; Pérez Simón, José Antonio; Prommersberger, Sabrina R. (Ferrata Storti Foundation, 2023)B-cell maturation antigen (BCMA) is the lead antigen for chimeric antigen receptor (CAR) T-cell therapy in multiple ...
-
Artículo
Publisher correction: Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab (Leukemia, (2021), 35, 1, (201-214), 10.1038/s41375-020-0840-y)
García-Guerrero, Estefanía; Götz, Ralph; Doose, Sören; Sauer, Markus; Rodríguez Gil, Alfonso; Pérez Simón, José Antonio; Danhof, Sophia (Springer Nature, 2022) -
Artículo
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab
García-Guerrero, Estefanía; Götz, Ralph; Doose, Sören; Sauer, Markus; Rodríguez Gil, Alfonso; Pérez Simón, José Antonio; Danhof, Sophia (Nature Publishing Group, 2021)Multiple myeloma (MM) is incurable, so there is a significant unmet need for effective therapy for patients with relapsed ...